Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2013 Dec 19;209(11):1705–1714. doi: 10.1093/infdis/jit825

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Figure 1. — Influenza A(H1N1)pdm09 hemagglutination inhibition antibody (HI) geometric mean titer (GMT) at 2010–2011 preseason (S1), about 30 days post–trivalent inactivated vaccine (TIV) (S2), and end-of-season (S3) among 834 TIV recipients, by those who received 2009 A(H1N1)pdm09 monovalent inactivated influenza vaccine (MIIV) vs those not vaccinated during the prior season and stratified by 2010–2011 preseason HI titers.